What Happens to the Veins From the Leg Used for Bypass Surgery?

The great saphenous vein, the long vein running from ankle to groin just beneath the skin, is removed from the leg and sewn onto the coronary arteries to reroute blood around blockages. Once transplanted, the vein faces an entirely new job: handling arterial blood pressure roughly five to ten times higher than what it was built for. Meanwhile, the donor leg loses its largest superficial vein and has to rely on its remaining deeper veins to carry blood back to the heart. Both the graft and the leg undergo real changes, and how well each adapts shapes the patient’s recovery and long-term outcome.

How the Vein Is Removed

Surgeons typically harvest the great saphenous vein using one of two approaches. The traditional open technique involves a long incision down the inner leg, giving the surgeon direct access to the vein along most of its length. The newer endoscopic method uses one or two small incisions and a camera-equipped instrument threaded along the vein. A randomized trial found that leg wound complications dropped from about 19% with the open technique to roughly 7% with endoscopic harvesting.¹ The REGROUP trial, one of the larger studies comparing the two approaches, confirmed that endoscopic harvesting reduced leg wound complications without increasing cardiovascular events over the intermediate term.²

Before harvesting, many surgical teams now use ultrasound to map the vein. The scan measures the vein’s diameter at multiple points along the leg and checks for problems like chronic clotting, varicose segments, or double venous systems that could make the vein unsuitable as a graft.³ Veins with a diameter between about 2 and 5 millimeters are considered usable; anything smaller tends to be too fragile, while veins larger than about 8 millimeters are typically ruled out because their walls are often abnormally thin or weakened.³ Duplex scanning also helps surgeons plan exactly where to make incisions, reducing unnecessary cutting.⁴

What Happens to the Vein Once It Becomes an Artery Graft

A vein is not an artery. Veins are thin-walled, low-pressure vessels designed to carry blood slowly back toward the heart. When a segment of saphenous vein is suddenly stitched onto the aorta and connected to a coronary artery, it is thrust into a high-pressure, pulsatile environment it was never designed for. The vein responds by remodeling: its wall thickens, and its smooth muscle layer bulks up to withstand the new forces.⁵ Some of this remodeling is healthy and necessary. The vein’s inner lining ramps up production of nitric oxide synthase, an enzyme that helps the vessel relax and regulate blood flow, within as little as 90 minutes of exposure to arterial pressure.⁶

But the remodeling process can go too far. The smooth muscle cells in the vein wall, which normally sit quietly, can shift into a more active state where they multiply and migrate into the inner lining of the graft. This overgrowth, called intimal hyperplasia, is one of the main reasons vein grafts narrow and eventually fail.⁷ Recent research has even found that some endothelial cells lining the vein begin to take on characteristics of smooth muscle cells when exposed to the shearing forces of arterial blood flow, blurring the boundary between cell types in ways that may fuel the problem.⁸

Beyond intimal hyperplasia, vein grafts are also prone to developing atherosclerosis, the same fatty-plaque disease that clogged the original coronary arteries. Compared with healthy arteries, saphenous vein grafts show poor ability to dilate in response to normal signals, which likely accelerates plaque buildup.⁹ The combination of wall thickening, intimal hyperplasia, and accelerated atherosclerosis is why vein graft disease follows a somewhat predictable timeline: early failures tend to be from clotting, mid-term failures from intimal hyperplasia, and late failures from atherosclerosis.

How Long Vein Grafts Last

A large Veterans Affairs cooperative study tracked graft patency over a decade. At ten years, about 61% of saphenous vein grafts remained open, compared with 85% of internal mammary artery grafts.¹⁰ That gap is one reason surgeons strongly prefer using the internal mammary artery for the most critical bypass, the one supplying the main artery of the heart’s left side. But most patients need more than one bypass, and there are only so many arterial conduits available. The saphenous vein remains the workhorse for additional grafts precisely because it is long, accessible, and available in quantity.

Understanding that roughly four in ten vein grafts will have failed by the decade mark puts the importance of post-surgical care into perspective. This is not a surgery you walk away from and forget about; it requires lifelong attention to medications, cholesterol, and follow-up imaging.

Keeping Grafts Open

Protecting a vein graft starts before the surgeon even sews it in. After the vein is removed from the leg, it sits in a storage solution while the surgical team prepares the heart. The choice of solution matters: buffered solutions appear to preserve the vein’s delicate inner lining better than simple saline, reducing cell damage during the waiting period.¹¹ Research on specific commercial solutions has shown that some reduce cell death during the first couple of hours of storage compared to standard physiological saline.¹²

After surgery, statins are the single most important medication for graft longevity. Multiple trials have shown that statins improve vein graft patency, and not just because they lower cholesterol. They also directly reduce inflammation in the graft wall, improve the lining’s ability to function, and slow the smooth muscle cell overgrowth that causes intimal hyperplasia.¹³ Current guidelines recommend starting statin therapy before the operation and continuing it for life.¹⁴ For patients who still have elevated cholesterol despite statins, adding other lipid-lowering drugs may provide further protection, though the evidence is still developing.¹⁴

What Happens to the Donor Leg

Losing the great saphenous vein does not cripple the leg’s circulation. The leg has a deep venous system that carries the vast majority of blood back to the heart anyway, and smaller superficial veins can take over some of the saphenous vein’s role. Still, the leg does not always recover seamlessly.

Swelling is the most common complaint. A large retrospective audit found that about 41% of patients reported swelling in the harvested leg, with more than half of those cases improving within three months. In roughly a quarter of patients who experienced swelling, it persisted beyond two years.¹⁵ The swelling is typically mild and manageable with compression stockings and leg elevation, but in rare cases it can progress to lymphedema, a more stubborn form of swelling caused by disruption of the leg’s lymphatic drainage during surgery. When lymphedema does develop, specialized decongestive therapy can reduce volume and improve quality of life.¹⁶

Numbness along the inner leg and ankle is even more universal than swelling, though patients tend to notice it less. The saphenous nerve runs alongside the vein for much of its course, and harvesting the vein often damages this nerve. One study examining legs three days after surgery found that 90% had some area of numbness. At a mean follow-up of 20 months, about 72% still had some sensory loss, though the affected area had shrunk significantly over time.¹⁷ Actual pain from nerve damage was infrequent; the main issue was patches of reduced sensation along the inner calf and ankle. Most patients describe it as an odd numb spot rather than anything disabling.

Wound infections, scarring, and prolonged pain round out the list of potential leg complications. Patients who develop severe wound infections at the harvest site report a significant toll on daily life, describing varying degrees of pain, anxiety, and limitation in their normal activities during the healing period.¹⁸ This is one area where endoscopic harvesting has a clear edge, since smaller incisions mean less tissue disruption and a lower risk of wound trouble.

Why the Leg Usually Does Fine Without Its Saphenous Vein

One of the more reassuring findings is that objective tests of venous function in the harvested leg tend to look normal even when patients report symptoms. A study measuring venous outflow capacity and checking for deep vein valve problems found no significant differences between harvested and non-harvested legs, and no clear relationship between measured venous function and patient-reported swelling.¹⁹ In other words, the deep venous system compensates well. The swelling that patients do experience seems to come more from tissue inflammation, lymphatic disruption, and fluid redistribution in the early months than from a fundamental failure of venous drainage.

This is relevant for patients who worry that losing the saphenous vein will leave them with a permanently compromised leg. It does not. The saphenous vein is actually removed electively in varicose vein surgery all the time, precisely because the deep veins handle blood return on their own. The same principle applies after bypass surgery, though the larger incision and associated tissue trauma mean the recovery curve can be steeper.

External Stenting of Vein Grafts

One of the more promising developments in vein graft protection is external stenting: wrapping the outside of the vein graft in a mesh scaffold at the time of surgery. The idea is straightforward. Much of the damage that triggers intimal hyperplasia comes from the sudden stretching of the thin vein wall when it is exposed to arterial pressure. An external support prevents over-dilation, keeps blood flow more uniform inside the graft, and reduces the mechanical stress that drives smooth muscle cells to proliferate.

A meta-analysis of studies using external stents found significant reductions in intimal hyperplasia and wall thickening in stented grafts compared with unstented ones.²⁰ The VEST trial, one of the key studies in this area, showed that externally stented grafts had a more uniform lumen and no thrombus formation at one year.²¹ Another study confirmed that external stenting reduces early postoperative graft failure.²² The technology is not yet standard practice everywhere, but it represents a real shift in thinking: rather than just managing graft disease after it develops, surgeons may be able to prevent much of it from the start.

When the Saphenous Vein Is Not Available

Sometimes the great saphenous vein cannot be used. It may have been previously harvested, stripped for varicose veins, or found to be too small or too damaged during preoperative mapping. In these cases, surgeons turn to alternative conduits. Other veins in the body, such as the small saphenous vein, arm veins, or spliced segments of multiple veins, can serve as grafts. These alternatives tend to have higher rates of needing additional procedures, though mid-term patency can be comparable to the great saphenous vein in some settings.²³

The picture is more complex for bypasses in the leg itself (as opposed to the heart). A study of below-knee bypasses found that single-segment great saphenous vein grafts outperformed alternative veins on every measure of long-term patency. At five years, secondary patency was 60% for great saphenous vein grafts versus 55% for alternative vein grafts. Perhaps unexpectedly, prosthetic (synthetic) grafts performed similarly to alternative veins in some measures.²⁴ The takeaway is that the great saphenous vein is genuinely the best option when it is available, and its absence requires a careful conversation between surgeon and patient about second-best choices.

The Saphenous Vein Beyond Heart Surgery

While coronary artery bypass gets the most attention, the saphenous vein is also used as a graft for blocked arteries in the legs themselves. In peripheral artery disease, where blood flow to the lower limbs is compromised, a saphenous vein bypass can reroute blood around long blockages in the thigh or calf. A study comparing saphenous vein bypass to stenting for long-segment blockages of the superficial femoral artery found that the vein bypass had higher patency at one year, with about 87% of bypasses remaining open compared with 60% of stents. Stenting offered shorter hospital stays, but the restenosis rate was more than double that of the vein graft.²⁵ This means that a patient who has already had their saphenous vein removed for a coronary bypass may have fewer options if they later develop severe peripheral artery disease, an underappreciated consequence that surgeons weigh during preoperative planning.

The versatility of the saphenous vein also explains why vascular surgeons urge caution about removing it for cosmetic varicose vein procedures in patients who have risk factors for coronary or peripheral artery disease. If that vein might be needed down the road as a bypass conduit, stripping it purely for cosmetic reasons is a trade-off worth discussing with a doctor who understands the full picture.